#32026D0578Commission Implementing Decision (EU) 2026/578 postponing the expiry date of the approval of alphachloralose for use in biocidal products of product-type 14
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This Commission Decision further postpones the expiry date of the approval of the active substance alphachloralose for biocidal products of product-type 14 (rodenticides) from 30 June 2026 to 31 December 2027. The delay is required because the Polish evaluating competent authority needs additional time to assess new studies on the substance’s endocrine-disrupting properties. Previous postponements occurred in 2021 and 2023 for similar evaluation delays. The substance therefore continues to remain approved under the existing conditions of Directive 98/8/EC until the new date while the renewal procedure under Regulation (EU) No 528/2012 is completed.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Postpones the approval expiry date of alphachloralose (product-type 14) from 30 June 2026 to 31 December 2027
- Additional studies required on endocrine-disrupting properties of the substance
- Renewal assessment report expected from Poland in Q2 2026
+ 3 more changes with Pro
Obligations
What this law requires
Alphachloralose approval for biocidal product-type 14 (rodenticides) remains valid and approved for use until 31 December 2027 under the conditions set out in Annex I to Directive 98/8/EC
The Polish evaluating competent authority must complete assessment of endocrine-disrupting properties studies and submit the renewal assessment report to the European Chemicals Agency by the second quarter of 2026
The European Chemicals Agency must prepare and submit its opinion on renewal of alphachloralose approval to the Commission within 270 days of receipt of the Polish competent authority's recommendation
The Commission must decide whether to renew the approval of alphachloralose for biocidal product-type 14 on or before 31 December 2027
Applicants for renewal must provide sufficient data to the Polish evaluating competent authority as requested to support evaluation of endocrine-disrupting, carcinogenic, reproductive toxic, and persistent-bioaccumulative-toxic properties